Innova Sierra Pty Ltd, in collaboration with leading Scientific, Commercial groups and Clinical practitioners, and partners has formed a new initiative called “ NextOmics Pty Ltd.” focused around “Next Generation Sequencing”, “Big Data for Life Sciences” and “Clinical applications”, based out of Melbourne, Australia. NextOmics focuses on market development, product and solution offerings, and Innovation. Innova Sierra will assist in structuring, formulating and execution of R&D, Innovation for NextOmics.
NextOmics is a Life Science initiative working towards the convergence of Clinical analysis, Pharma, Biotechnology, Food and Population Genetics leading to Predictive Preventive Personalized Healthcare.
The business model of NextOmics is to combine Intellectual Property, analysis, and Product Development through in-house and collaborative Research & Development initiatives in Life Sciences and Big Data analysis. NextOmics has, through its partners, will continues to build an integrated, systems biology approach of capabilities, products, infrastructure and technology that allows for and facilitates cross communication between numerous disciplines, leading to unique and innovative solutions.
NextOmics, is also focused on Personalised Genetic Analysis to individuals and client organisations, which can offer genetic diagnostic services to hospitals, physicians and healthcare organizations.
NextOmics has access through its partners who have developed a High Performance, High Accuracy, High Impact unified sequence analytics software solution for management, analysis, interpretation and sharing of NGS data and results. The focus of NextOmics initiative is to build a robust platform addressing the complexities of Sequencing Big Data in Life Sciences for driving actionable insights with ease and accuracy.
R and D
Conduct R&D in Next Generation Sequencing in collaboration with local Medical, Agricultural, Veterinary and Biotechnology practitioners and Researchers, for personalised